P708: CANADIAN AND RUSSIAN EXPERIENCES OF ASCIMINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WHO FAILED MULTIPLE LINES OF TYROSINE KINASE INHIBITOR (TKI) THERAPY. (23rd June 2022) - Khadadah, F.; Turkina, A. G.; Lomaia, E.; Morozova, E. V.; Shukhov, O. A.; Petrova, A.; Chitanava, T.; Vlasova, J. J.; Kuzmina, E.; Nemchenko, I.; Chelysheva, E. Y.; Bykova, A.; et al.